Ipilimumab (anti-CTLA-4) ExactAb™, Validated, Carrier Free, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
I411993-100ΜG / 100ΜG
CAS No.:477202-00-9
Ipilimumab (anti-CTLA-4) ExactAb™, Validated, Carrier Free, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
I411993-10MG / 10MG
CAS No.:477202-00-9
Ipilimumab (anti-CTLA-4) ExactAb™, Validated, Carrier Free, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
I411993-1MG / 1MG
CAS No.:477202-00-9
Ipilimumab (anti-CTLA-4) ExactAb™, Validated, Carrier Free, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
I411993-5MG / 5MG
CAS No.:477202-00-9
Infliximab (anti-TNF-alpha) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
I412009-100ΜG / 100ΜG
CAS No.:170277-31-3
Infliximab (anti-TNF-alpha) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
I412009-10MG / 10MG
CAS No.:170277-31-3
Infliximab (anti-TNF-alpha) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
I412009-1MG / 1MG
CAS No.:170277-31-3
Infliximab (anti-TNF-alpha) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
I412009-5MG / 5MG
CAS No.:170277-31-3